Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Generate Biomedicines Inc (GENB)

86 + Investors. Track Smart Money conviction in GENB. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +31
Streak
1Q ▲
Buyers last Q
75%

Smart Money Signals — GENB

Based on 86 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 1Q
For 1 consecutive quarter, more hedge funds added GENB than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
86 hedge funds hold GENB right now — the highest count in 0.5 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🟢

More buyers than sellers — 75% buying

67 buying22 selling
Last quarter: 67 funds were net buyers (44 opened a brand new position + 23 added to an existing one). Only 22 were sellers (9 trimmed + 13 sold completely). A clear majority buying is a strong confirmation signal.
🔄

Mostly new holders — 100% entered in last year

■ 0% conviction (2yr+) ■ 0% medium ■ 100% new
Only 0 funds (0%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.
💰

Value +51% but shares only +12% — price-driven

Value
+51%
Shares
+11%
Last quarter: the total dollar value of institutional holdings rose +51%, but actual share count only changed +12%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
🌱

Early stage — 100% of holders entered in last year

■ 0% veterans ■ 0% 1-2yr ■ 100% new
Of 86 current holders: 86 (100%) entered in the past year, only 0 (0%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.
📋

Smaller funds dominant — 18% AUM from top-100

18% from top-100 AUM funds
31 of 86 holders rank in the top 100 by AUM, but together hold only 18% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
5.5
out of 10
Moderate Exit Risk
Exit risk score 5.5/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — GENB

In 2026 Q2, 67 hedge funds were net buyers of GENB (44 opened a new position, 23 added to an existing one), while 22 reduced or exited (9 trimmed, 13 sold completely) — a 75% buyer ratio, indicating clear institutional accumulation. Net fund flow last quarter: +31 funds (more new holders than closures). Total institutional holders: 86.

Hedge Fund Ownership: GENB

How many hedge funds hold GENB — quarterly history vs. share price
Quarterly hedge fund ownership of GENB vs. share price

Market Analysis: GENB

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: GENB

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Loading signal freshness…
Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

7 top-rated funds 3 high-conviction
Consensus
3.9
/ 10
breadth
×
Elite
2.4
/ 10
conviction
Hedge Fund Positioning: GENB
2026 Q3 Stats Unlock in 10 days 86 + Investors

Track Smart Money conviction in GENB. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 86 55 56.36%
13F Shares 100M 90M 11.68%
Total Value $1.65B $1.09B 51.05%
New Positions 44 55 -11
Increased Positions 23 0 +23
Closed Positions 13 0 +13
Reduced Positions 9 0 +9
Total Calls 0 1 -100.0%
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: GENB

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

86 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in GENB. Verified SEC 13F-HR filings.

QUARTER:
Top 25 GENB holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Flagship Pioneering, LLC 68.66% 62,673,117 $1.06B
2 Harbourvest Partners LLC 17.09% 1,722,210 $29.1M
3 ARCH Venture Management, LLC 2.98% 1,944,426 $32.8M
4 Davern Capital Partners, LP 2.37% 824,679 $13.9M
5 Braidwell LP 2.05% 3,283,844 $55.4M
6 Sphera Funds Management LTD. 0.54% 245,000 $4.1M
7 Harvard Management Co Inc 0.44% 1,111,100 $18.7M
8 Deep Track Capital, LP 0.33% 1,333,815 $22.5M
9 Affinity Asset Advisors, LLC 0.30% 400,000 $6.7M
10 Siren, L.L.C. 0.25% 736,104 $12.4M
11 ARK Investment Management LLC 0.14% 1,284,617 $21.7M
12 Baker BROS. Advisors LP 0.12% 1,423,602 $24.0M
13 CenterBook Partners LP 0.11% 131,560 $2.2M
14 Virtus Investment Advisers, LLC 0.10% 26,430 $446K
15 Seven Grand Managers, LLC 0.08% 125,000 $2.1M
16 IQ EQ FUND MANAGEMENT (IRELAND) Ltd 0.04% 37,226 $628K
17 Axq Capital, LP 0.02% 12,946 $218K
18 Nvidia Corp 0.02% 833,325 $14.1M
19 Magnus Financial Group LLC 0.02% 15,600 $263K
20 Alps Advisors Inc 0.01% 129,406 $2.2M
21 Capital World Investors 0.01% 4,215,632 $71.1M
22 Amova Asset Management Americas, Inc. 0.01% 38,218 $644K
23 Stance Capital LLC 0.01% 1,384 $23K
24 LMR Partners LLP 0.01% 100,000 $1.7M
25 Benson Wealth Management INC 0.01% 363 $6K
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Generate Biomedicines Inc (GENB)

What does the Smart Money Trend signal show for GENB?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added GENB than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for GENB?

More buyers than sellers — 75% buying: Last quarter: 67 funds were net buyers (44 opened a brand new position + 23 added to an existing one). Only 22 were sellers (9 trimmed + 13 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for GENB holders?

Smaller funds dominant — 18% AUM from top-100: 31 of 86 holders rank in the top 100 by AUM, but together hold only 18% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held GENB?

Mostly new holders — 100% entered in last year: Only 0 funds (0%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →